- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S7079
| Related Targets | HDAC JAK BET PKC PARP HIF PRMT EZH2 AMPK Histone Acetyltransferase |
|---|---|
| Other Histone Methyltransferase Products | 3-Deazaneplanocin A (DZNep) Hydrochloride Pinometostat (EPZ5676) BIX-01294 trihydrochloride EPZ004777 EPZ015666 (GSK3235025) UNC1999 EPZ005687 MM-102 UNC0638 EPZ011989 |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| human MCF10A cells | Function assay | Inhibition of DOT1L in human MCF10A cells assessed as reduction of H3K79 level, IC50=0.0088 μM | ||||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 100 mg/mL
(161.66 mM)
Ethanol : 100 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 618.57 | Formula | C28H40BrN7O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1561178-17-3 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O | ||
| Features |
Cell-active DOT1L-selective chemical probe.
|
|---|---|
| Targets/IC50/Ki |
DOT1L
(Cell-free assay) 0.3 nM
|
| In vitro |
SGC 0946 is over 100-fold selective for other histone methyltransferases/HMTs. This compound potently reduces H3K79 dimethylation with IC50 of 2.6 nM in A431 cells, and 8.8 nM in MCF10A cells, which potently and selectively kills cells containing an MLL translocation. It is much more potent than its close analog EPZ004777, and serves as an excellent chemical probe for investigating DOT1L and further development of DOT1L inhibitors for cancer therapy. |
| In vivo |
SGC0946, a highly potent and selective DOT1L methyltransferase inhibitor, resulted in significant inhibition of tumor progression in the ovarian orthotopic xenograft mice model. |
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | DOT1L / H3K79me2 / CDK6 / Cyclin D3 |
|
28114995 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.